Triple negative breast cancer: a heterogeneous subgroup defined by what it is not.

Suppr

超能文献

作者信息

Oakman Catherine, Moretti Erica, Pacini Giulia, Santarpia Libero, Di Leo Angelo

机构信息

Sandro Pitigliani Medical Oncology Unit, Hospital of Prato, Istituto Toscano, Tumori, Italy.

出版信息

Eur J Cancer. 2011 Sep;47 Suppl 3:S370-2. doi: 10.1016/S0959-8049(11)70207-6.

DOI:10.1016/S0959-8049(11)70207-6

PMID:21944019

Abstract

摘要

相似文献

Triple negative breast cancer: a heterogeneous subgroup defined by what it is not.

Eur J Cancer. 2011 Sep;47 Suppl 3:S370-2. doi: 10.1016/S0959-8049(11)70207-6.

Assessment of RT-PCR detection of human mammaglobin for the diagnosis of breast cancer derived pleural effusions.评估逆转录聚合酶链反应（RT-PCR）检测人乳腺珠蛋白在诊断乳腺癌源性胸腔积液中的应用。

Diagn Mol Pathol. 2008 Mar;17(1):28-33. doi: 10.1097/PDM.0b013e31811ffe3b.

Gene expression profiling: decoding breast cancer.基因表达谱分析：解读乳腺癌

Surg Oncol. 2009 Dec;18(4):366-78. doi: 10.1016/j.suronc.2009.07.005.

Glycoprotein nonmetastatic B is an independent prognostic indicator of recurrence and a novel therapeutic target in breast cancer.糖蛋白非转移性 B 是乳腺癌复发的独立预后指标和新的治疗靶点。

Clin Cancer Res. 2010 Apr 1;16(7):2147-56. doi: 10.1158/1078-0432.CCR-09-1611. Epub 2010 Mar 9.

Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma.缺氧诱导因子-1α水平可独立预测淋巴结阴性乳腺癌患者的预后。

Cancer. 2003 Mar 15;97(6):1573-81. doi: 10.1002/cncr.11246.

New molecular classifications of breast cancer.乳腺癌的新分子分类

CA Cancer J Clin. 2009 Sep-Oct;59(5):303-13. doi: 10.3322/caac.20029.

Expression array technology in the diagnosis and treatment of breast cancer.表达阵列技术在乳腺癌诊断与治疗中的应用

Mol Interv. 2002 Apr;2(2):101-9. doi: 10.1124/mi.2.2.101.

Integration of DNA copy number alterations and prognostic gene expression signatures in breast cancer patients.乳腺癌患者中 DNA 拷贝数改变与预后基因表达特征的整合。

Clin Cancer Res. 2010 Jan 15;16(2):651-63. doi: 10.1158/1078-0432.CCR-09-0709. Epub 2010 Jan 12.

EGFR expression and gene copy number in triple-negative breast carcinoma.三阴性乳腺癌中的表皮生长因子受体（EGFR）表达及基因拷贝数

Cancer Genet Cytogenet. 2010 Dec;203(2):222-9. doi: 10.1016/j.cancergencyto.2010.07.118.

Cytomorphology of common malignant tumors of the breast.乳腺常见恶性肿瘤的细胞形态学

Clin Lab Med. 2005 Dec;25(4):733-60, vii. doi: 10.1016/j.cll.2005.08.008.

引用本文的文献

Correlation between the Expression of PD-L1 and Clinicopathological Parameters in Triple Negative Breast Cancer Patients.三阴性乳腺癌患者中PD-L1表达与临床病理参数的相关性

Eur J Breast Health. 2019 Oct 1;15(4):235-241. doi: 10.5152/ejbh.2019.4912. eCollection 2019 Oct.

[(18)F]FluorThanatrace uptake as a marker of PARP1 expression and activity in breast cancer.[(18)F]氟代死亡示踪剂摄取作为乳腺癌中PARP1表达和活性的标志物。

Am J Nucl Med Mol Imaging. 2016 Jan 28;6(1):94-101. eCollection 2016.

Gene expression profiling leads to discovery of correlation of matrix metalloproteinase 11 and heparanase 2 in breast cancer progression.基因表达谱分析揭示了基质金属蛋白酶11和乙酰肝素酶2在乳腺癌进展中的相关性。

BMC Cancer. 2015 Jun 18;15:473. doi: 10.1186/s12885-015-1410-y.

Novel treatment strategies in triple-negative breast cancer: specific role of poly(adenosine diphosphate-ribose) polymerase inhibition.三阴性乳腺癌的新型治疗策略：聚（二磷酸腺苷 - 核糖）聚合酶抑制的特定作用

Pharmgenomics Pers Med. 2014 Oct 3;7:307-16. doi: 10.2147/PGPM.S39765. eCollection 2014.

Lack of prognostic significance of adiponectin immunohistochemical expression in patients with triple-negative breast cancer.脂联素免疫组化表达在三阴性乳腺癌患者中缺乏预后意义。

Contemp Oncol (Pozn). 2014;18(1):34-8. doi: 10.5114/wo.2014.40454. Epub 2014 Feb 28.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验